Sign in

CIK 0001768224 · Accelerated filer<br>Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
8589002660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  6. 8-K Event Regulation FD disclosure
  7. UPLOAD Other SEC-generated Letter
  8. S-3 Offering Registration Statement
  9. 4 Open-market buy Chief Financial Officer bought 5,649 shares at $9.73 ($54,965)
  10. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $10.00 ($100,000)
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 8-K Event Regulation FD disclosure
  14. 8-K Event Material agreement · Shareholder vote results
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. DEF 14A Proxy Proxy Statement

Page 19 of 21 · 416 filings